Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.

Elena Shagisultanova

TitleAsst Professor
InstitutionUniversity of Colorado Denver - Anschutz Medical Campus
DepartmentSOM-MED

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Weiss J, Afghahi A, Shagisultanova E, Diamond JR. Approaching Use of CDK4/6 Inhibitors in Metastatic HR+, HER2- Breast Cancer. Oncology (Williston Park). 2018 10 15; 32(10):513-5. PMID: 30334242.
      View in: PubMed
    2. Schedin TB, Borges VF, Shagisultanova E. Overcoming Therapeutic Resistance of Triple Positive Breast Cancer with CDK4/6 Inhibition. Int J Breast Cancer. 2018; 2018:7835095. PMID: 30018827.
      View in: PubMed
    3. Shagisultanova E, Mayordomo J, Elias AD. Triple-negative breast cancer in the elderly. Breast J. 2017 11; 23(6):627-629. PMID: 29112794.
      View in: PubMed
    4. Lev A, Deihimi S, Shagisultanova E, Xiu J, Lulla AR, Dicker DT, El-Deiry WS. Preclinical rationale for combination of crizotinib with mitomycin C for the treatment of advanced colorectal cancer. Cancer Biol Ther. 2017 Sep 02; 18(9):694-704. PMID: 28886275.
      View in: PubMed
    5. Deihimi S, Lev A, Slifker M, Shagisultanova E, Xu Q, Jung K, Vijayvergia N, Ross EA, Xiu J, Swensen J, Gatalica Z, Andrake M, Dunbrack RL, El-Deiry WS. BRCA2, EGFR, and NTRK mutations in mismatch repair-deficient colorectal cancers with MSH2 or MLH1 mutations. Oncotarget. 2017 Jun 20; 8(25):39945-39962. PMID: 28591715.
      View in: PubMed
    6. Jasem J, Fisher CM, Amini A, Shagisultanova E, Rabinovitch R, Borges VF, Elias A, Kabos P. The 21-Gene Recurrence Score Assay for Node-Positive, Early-Stage Breast Cancer and Impact of RxPONDER Trial on Chemotherapy Decision-Making: Have Clinicians Already Decided? J Natl Compr Canc Netw. 2017 04; 15(4):494-503. PMID: 28404760.
      View in: PubMed
    7. Overholser L, Shagisultanova E, Rabinovitch RA, Kounalakis N, Diamond J, Finlayson CA, Fisher CM, Kabos P, Elias AD, Borges VF, Mayordomo J. Breast Cancer Following Radiation for Hodgkin Lymphoma: Clinical Scenarios and Risk-Reducing Strategies. Oncology (Williston Park). 2016 12 15; 30(12):1063-70. PMID: 27987198.
      View in: PubMed
    8. Beck TN, Georgopoulos R, Shagisultanova EI, Sarcu D, Handorf EA, Dubyk C, Lango MN, Ridge JA, Astsaturov I, Serebriiskii IG, Burtness BA, Mehra R, Golemis EA. EGFR and RB1 as Dual Biomarkers in HPV-Negative Head and Neck Cancer. Mol Cancer Ther. 2016 10; 15(10):2486-2497. PMID: 27507850.
      View in: PubMed
    9. Shagisultanova E, Gaponova AV, Gabbasov R, Nicolas E, Golemis EA. Preclinical and clinical studies of the NEDD9 scaffold protein in cancer and other diseases. Gene. 2015 Aug 01; 567(1):1-11. PMID: 25967390; PMCID: PMC4458429.
      View in: PubMed, PubMed Central
    10. Shagisultanova E, Dunbrack RL, Golemis EA. Issues in interpreting the in vivo activity of Aurora-A. Expert Opin Ther Targets. 2015 Feb; 19(2):187-200. PMID: 25384454; PMCID: PMC4294965.
      View in: PubMed, PubMed Central
    11. Shagisultanova EI, Piao Z, Li HR, Malkhosyan SR. Topoisomerase II gene mutations in tumors and tumor cell lines with microsatellite instability. Cancer Lett. 2004 Dec 28; 216(2):221-6. PMID: 15533598.
      View in: PubMed
    12. Li HR, Shagisultanova EI, Yamashita K, Piao Z, Perucho M, Malkhosyan SR. Hypersensitivity of tumor cell lines with microsatellite instability to DNA double strand break producing chemotherapeutic agent bleomycin. Cancer Res. 2004 Jul 15; 64(14):4760-7. PMID: 15256444.
      View in: PubMed
    13. Shagisultanova EI, Novikova IA, Sidorenko YS, Marchenko GN, Strongin AY, Malkhosyan SR. The matrix metalloproteinase-21 gene 572C/T polymorphism and the risk of breast cancer. Anticancer Res. 2004 Jan-Feb; 24(1):199-201. PMID: 15015597.
      View in: PubMed
    14. Mustafina OE, Shagisultanova EI, Tuktarova IA, Khusnutdinova EK. [Polymorphism of the apolipoprotein E gene and the risk of myocardial infarction]. Mol Biol (Mosk). 2002 Nov-Dec; 36(6):978-84. PMID: 12500534.
      View in: PubMed
    15. Mustafina OE, Shagisultanova EI, Nasibullin TR, Tuktarova IA, Bikmeeva AM, Poliudova ON, Khusnutdinova EK. [Endothelial nitric oxide synthase gene minisatellite polymorphism: study in populations of the Volga-Ural region and analysis of associations with myocardial infarct and essential hypertension]. Genetika. 2001 May; 37(5):668-74. PMID: 11436560.
      View in: PubMed
    16. Mustafina OE, Shagisultanova EI, Tuktarova IA, Khusnutdinova EK. [Connection of HindIII-polymorphism of the lipoprotein lipase gene with risk of developing myocardial infarct]. Mol Biol (Mosk). 2001 May-Jun; 35(3):401-3. PMID: 11443920.
      View in: PubMed
    17. Shagisultanova EI, Mustafina OE, Tuktarova IA, Khusnutdinova EK. [HindIII polymorphism of lipoprotein lipase gene and risk of myocardial infarction]. Mol Gen Mikrobiol Virusol. 2001; (3):18-22. PMID: 11534394.
      View in: PubMed
    Shagisultanova's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    See all (117) concept(s)
    _
    Co-Authors Expand Description
    See all (10) people
    _
    Similar People Expand Description
    See all (60) people
    _
    Same Department Expand Description
    Search Department
    Physical Neighbors Expand Description
    _

    Copyright © 2017 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.10.0)